CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dugel Pravin −$233K Reporting owner sold <1% of stake
- Saroj Namrata −$232K Chief Business Officer sold 14% of stake
- Heier Jeffrey S. −$112K Chief Scientific Officer sold 4% of stake
- Kaiser Peter −$103K Chief Development Officer sold 5% of stake
- Anderman Todd −$87K Chief Legal Officer sold 8% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-10 | LINDSTROM RICHARD L MD Director | Grant or award | +14,000 | 260,933 | ||
| 2026-06-10 | LINDSTROM RICHARD L MD Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2026-02-20 | LINDSTROM RICHARD L MD Director | Purchase | +60,229 | $7.66 | $461K | 246,933 |
| 2025-06-11 | LINDSTROM RICHARD L MD Director | Grant or award | +14,000 | 143,145 | ||
| 2025-06-11 | LINDSTROM RICHARD L MD Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2025-05-08 | LINDSTROM RICHARD L MD Director | Purchase | +10,000 | $6.96 | $70K | 172,704 |
| 2024-07-24 | LINDSTROM RICHARD L MD Director | Grant or award | +12,000 | 162,704 | ||
| 2024-07-24 | LINDSTROM RICHARD L MD Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2024-02-27 | LINDSTROM RICHARD L MD Director | Exercise or conversion | +18,939 | $8.80 | $167K | 139,341 |
| 2024-02-27 | LINDSTROM RICHARD L MD Director | Exercise or conversion | +11,363 | $8.80 | $100K | 150,704 |
| 2024-02-27 | LINDSTROM RICHARD L MD Director | Exercise or conversion · Stock Option (Right to Buy) | −18,939 | 0 | ||
| 2024-02-27 | LINDSTROM RICHARD L MD Director | Exercise or conversion · Stock Option (Right to Buy) | −11,363 | 0 | ||
| 2023-06-14 | LINDSTROM RICHARD L MD Director | Grant or award | +12,000 | 120,402 | ||
| 2023-06-14 | LINDSTROM RICHARD L MD Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2022-06-16 | LINDSTROM RICHARD L MD Director | Grant or award | +8,933 | 108,402 | ||
| 2022-06-16 | LINDSTROM RICHARD L MD Director | Grant or award · Stock Option (Right to Buy) | +26,800 | 26,800 | ||
| 2022-05-12 | LINDSTROM RICHARD L MD Director | Exercise or conversion | +9,469 | $1.22 | $12K | 99,469 |
| 2022-05-12 | LINDSTROM RICHARD L MD Director | Exercise or conversion · Stock Option (Right to Buy) | −9,469 | 0 | ||
| 2021-06-18 | LINDSTROM RICHARD L MD Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-05-20 | LINDSTROM RICHARD L MD Director | Sale | −10,000 | $14.30 | $143K | 90,000 |
Page 1 of 2 · 33 trades